{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Natural product chemistry", "Pharmaceutical chemistry"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": [], "GeneralNote": [], "PMID": "30302410", "DateRevised": {"Year": "2024", "Month": "04", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "10", "Day": "03"}], "Language": ["eng"], "ELocationID": ["e00829", "10.1016/j.heliyon.2018.e00829"], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "4", "Issue": "10", "PubDate": {"Year": "2018", "Month": "Oct"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Xanthine scaffold: scope and potential in drug development.", "Pagination": {"StartPage": "e00829", "MedlinePgn": "e00829"}, "Abstract": {"AbstractText": ["Medicinal plants have been the basis for discovery of various important marketed drugs. Xanthine is one such lead molecule. Xanthines in various forms (caffeine, theophylline, theobromine, etc) are abode in tea, coffee, cocoa, chocolate etc. giving them popular recognition. These compounds are best known for their diverse pharmaceutical applications as cyclic nucleotide phosphodiesterase inhibition, antagonization of adenosine receptor, anti-inflammatory, anti-microbial, anti-oxidant and anti-tumor activities. These properties incentivize to use xanthine as scaffold to develop new derivatives. Chemical synthesis contributes greater diversity in xanthine based derivatisation. With highlighting the existing challenges in chemical synthesis, the present review focuses the probable solution to fill existing lacuna. The review summarizes the available knowledge of xanthine based drugs development along with exploring new xanthine led chemical synthesis path for bringing diversification in xanthine based research. The main objective of this review is to explore the immense potential of xanthine as scaffold in drug development."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India."}], "LastName": "Singh", "ForeName": "Nivedita", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Kathmandu University, Nepal."}], "LastName": "Shreshtha", "ForeName": "Ashwinee Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Fermentation Technology and Bioengineering Department, Central Food Technological Research Institute, Mysore, India."}], "LastName": "Thakur", "ForeName": "M S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India."}], "LastName": "Patra", "ForeName": "Sanjukta", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Amirkia V., Heinrich M. Alkaloids as drug leads \u2013 a predictive structural and biodiversity-based analysis. Phytochem Lett. 2014;10 xlviii\u2013liii."}, {"Citation": "Cushnie T.P.T., Cushnie B., Lamb A.J. Alkaloids: an overview of their antibacterial, antibiotic-enhancing and antivirulence activities. Int. J. Antimicrob. Agents. 2014;44:377\u2013386.", "ArticleIdList": ["25130096"]}, {"Citation": "Perviz S., Khan H., Pervaiz A. Plant alkaloids as an emerging therapeutic alternative for the treatment of depression. Front. Pharmacol. 2016;7:1\u20137.", "ArticleIdList": ["PMC4753303", "26913004"]}, {"Citation": "Baraldi P.G., Fruttarolo F., Tabrizi M.A., Romagnoli R., Preti D. Novel 8-heterocyclyl xanthine derivatives in drug development - an update. Expet Opin. Drug Discov. 2007;2:1161\u20131183.", "ArticleIdList": ["23496127"]}, {"Citation": "S. Delarcina Jr., C. R. Ferrari, Process for obtaining extracts containing methylxanthine derivatives from cakes of plants of the genus Theobroma, as well as composition and use of said extract. US 9198848 B2 2009."}, {"Citation": "Monteiro J.P., Alves M.G., Oliveira P.F., Silva B.M. Structure-bioactivity relationships of methylxanthines: trying to make sense of all the promises and the drawbacks. Molecules. 2016;21:1\u201332.", "ArticleIdList": ["PMC6273298", "27472311"]}, {"Citation": "Ogawa K., Takagi K., Satake T. Mechanism of xanthine-induced relaxation of Guinea-pig isolated trachealis muscle. Br. J. Pharmacol. 1989;97:542\u2013546.", "ArticleIdList": ["PMC1854524", "2547475"]}, {"Citation": "Schmidt D.T., Watson N., Dent G., R\u00fchlmann E., Branscheid D., Magnussen H. The effect of selective and non-selective phosphodiesterase inhibitors on allergen- and leukotriene C(4)-induced contractions in passively sensitized human airways. Br. J. Pharmacol. 2000;131:1607\u20131618.", "ArticleIdList": ["PMC1572487", "11139438"]}, {"Citation": "Schroeder J.A., Ruta J.D., Gordon J.S., Rodrigues A.S., Foote C.C. The phosphodiesterase inhibitor isobutylmethylxanthine attenuates behavioral sensitization to cocaine. Behav. Pharmacol. 2012;23:310\u2013314.", "ArticleIdList": ["22495185"]}, {"Citation": "Meskini N., N\u00e9moz G., Okyayuz-Baklouti I., Lagarde M., Prigent A.-F. Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem. Pharmacol. 1994;47:781\u2013788.", "ArticleIdList": ["8135854"]}, {"Citation": "Burbiel J.C., Hockemeyer J., M\u00fcller C.E. Microwave-assisted ring closure reactions\u202f: synthesis of 8-substituted xanthine derivatives and related pyrimido- and diazepinopurinediones. Beilstein J. Org. Chem. 2006;63:1\u20136.", "ArticleIdList": ["PMC1698928", "17067400"]}, {"Citation": "Allwood M.B., Cannan B., van Aalten D.M.F., Eggleston I.M. Efficient synthesis of 1,3,7-substituted xanthines by a safety-catch protection strategy. Tetrahedron. 2007;63:12294\u201312302."}, {"Citation": "Suravajhala R., Poddar R., Nallapeta S., Ullah S. Agric. Bioinforma. Springer India; New Delhi: 2014. Xanthine derivatives: a molecular modeling perspective; pp. 283\u2013291."}, {"Citation": "Van der Walt M.M., Terre'Blanche G. 1,3,7-Triethyl-substituted xanthines\u2014possess nanomolar affinity for the adenosine A1 receptor. Bioorg. Med. Chem. 2015;23:6641\u20136649.", "ArticleIdList": ["26392370"]}, {"Citation": "Glennon R.A., Gaines J.J., Rogers M.E. Benz-fused mesoionic xanthine analogs as inhibitors of cyclic-AMP phosphodiesterase. J. Med. Chem. 1981;24:766\u2013769.", "ArticleIdList": ["6265639"]}, {"Citation": "Wong E.H.-A., Ooi S.-O. Methylxanthine and non-xanthine phosphodiesterase inhibitors: their effects on adenosine uptake and the low Km cyclic AMP phosphodiesterase in intact rat adipocyte. Biochem. Pharmacol. 1985;34:2891\u20132896.", "ArticleIdList": ["2411270"]}, {"Citation": "Haginaka J., Wakai J., Yasuda H., Kimura Y. Determination of anticonvulsant drugs and methyl xanthine derivatives in serum by liquid chromatography with direct injection: column-switching method using a new internal-surface reversed-phase silica support as a precolumn. J. Chromatogr. B Biomed. Sci. Appl. 1990;529:455\u2013461.", "ArticleIdList": ["2172268"]}, {"Citation": "Constantin S., Lupascu F.G., Apotrosoaei M., Vasincu I.M., Lupascu D., Buron F. Synthesis and biological evaluation of the new 1,3-dimethylxanthine derivatives with thiazolidine-4-one scaffold. Chem. Cent. J. 2017;11:12.", "ArticleIdList": ["PMC5289128", "28203273"]}, {"Citation": "Dai Z.-K., Liu Y.-W., Hsu J.-H., Yeh J.-L., Chen I.-J., Wu J.-R. The xanthine derivative KMUP-1 attenuates serotonin-induced vasoconstriction and K+-Channel inhibitory activity via the PKC pathway in pulmonary arteries. Int. J. Biol. Sci. 2015;11:633\u2013642.", "ArticleIdList": ["PMC4440253", "25999786"]}, {"Citation": "Heizmann G., Eberle A.N. Xanthines as a scaffold for molecular diversity. Mol. Divers. 1997;2:171\u2013174.", "ArticleIdList": ["9238648"]}, {"Citation": "Hayallah A.M., Sandoval-Ram\u00edrez J., Reith U., Schobert U., Preiss B., Schumacher B. 1,8-Disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. J. Med. Chem. 2002;45:1500\u20131510.", "ArticleIdList": ["11906291"]}, {"Citation": "Hayallah A.M., Elgaher W.A., Salem O.I., Alim A., Alim M.A. Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities. Arch Pharm. Res. (Seoul) 2011;34:3\u201321.", "ArticleIdList": ["21468910"]}, {"Citation": "Basu S., Barawkar D.A., Ramdas V., Patel M., Waman Y., Panmand A. Design and synthesis of novel xanthine derivatives as potent and selective A 2B adenosine receptor antagonists for the treatment of chronic inflammatory airway diseases. Eur. J. Med. Chem. 2017;134:218\u2013229.", "ArticleIdList": ["28415011"]}, {"Citation": "Sakai R., Konno K., Yamamoto Y., Sanae F., Takagi K., Hasegawa T. Effects of alkyl substitutions of xanthine skeleton on bronchodilation. J. Med. Chem. 1992;35:4039\u20134044.", "ArticleIdList": ["1331453"]}, {"Citation": "Kim D., Jun H., Lee H., Hong S.-S., Hong S. Development of new fluorescent xanthines as kinase inhibitors. Org. Lett. 2010;12:1212\u20131215.", "ArticleIdList": ["20184370"]}, {"Citation": "Bandyopadhyay P., Agrawal S.K., Sathe M., Sharma P., Kaushik M.P. A facile and rapid one-step synthesis of 8-substituted xanthine derivatives via tandem ring closure at room temperature. Tetrahedron. 2012;68:3822\u20133827."}, {"Citation": "Chen Y., Wang B., Guo Y., Zhou Y., Pan L., Xiong L. Synthesis and biological activities of novel methyl xanthine derivatives. Chem. Res. Chin. Univ. 2014;30:98\u2013102."}, {"Citation": "Lee D., Lee S., Liu K.H., Bae J.S., Baek D.J., Lee T. Solid-Phase synthesis of 1,3,7,8-tetrasubstituted xanthine derivatives on traceless solid support. ACS Comb. Sci. 2016;18:70\u201374.", "ArticleIdList": ["26616892"]}, {"Citation": "Gulevskaya A.V., Pozharskii A.F. Synthesis of N-substituted xanthines (review) Chem. Heterocycl. Comp. 1991;27:1\u201323."}, {"Citation": "Singh N., Saravanan P., Thakur M.S., Patra S. Development of xanthine based inhibitors targeting phosphodiesterase 9A. Lett. Drug Des. Discov. 2017;14:1\u201316."}, {"Citation": "Lee I., Kamba A., Low D., Mizoguchi E. Novel methylxanthine derivative-mediated anti-inflammatory effects in inflammatory bowel disease. World J. Gastroenterol. 2014;20:1127\u20131138.", "ArticleIdList": ["PMC3921497", "24574789"]}, {"Citation": "Franco R., O\u00f1atibia-Astibia A., Mart\u00ednez-Pinilla E. Health benefits of methylxanthines in cacao and chocolate. Nutrients. 2013;5:4159\u20134173.", "ArticleIdList": ["PMC3820066", "24145871"]}, {"Citation": "Miyamoto K., Yamamoto Y., Kurita M., Sakai R., Konno K., Sanae F. Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position. J. Med. Chem. 1993;36:1380\u20131386.", "ArticleIdList": ["8496906"]}, {"Citation": "M\u00fcller C.E., Deters D., Dominik A., Pawlowski M. Synthesis of paraxanthine and isoparaxanthine analogs (1,7- and 1,9- substituted xanthine derivatives) Synthesis. 1998:1428\u20131436."}, {"Citation": "Bansal R., Kumar G., Gandhi D., Yadav R., Young L.C., Harvey A.L. Synthesis of 8-(cyclopentyloxy)phenyl substituted xanthine derivatives as adenosine A2A ligands. Arzneimittelforschung. 2010;60:131\u2013136.", "ArticleIdList": ["20422944"]}, {"Citation": "McCarthy A.A., McCarthy J.G. The structure of two N-methyltransferases from the caffeine biosynthetic pathway. Plant Physiol. (Sofia) 2007;144:879\u2013889.", "ArticleIdList": ["PMC1914188", "17434991"]}, {"Citation": "Frischknecht P.M., Ulmer-Dufek J., Baumann T.W. Purine alkaloid formation in buds and developing leaflets of Coffea arabica: expression of an optimal defence strategy? Phytochemistry. 1986;25:613\u2013616."}, {"Citation": "Nathanson J.A. Caffeine and related methylxanthines: possible naturally occurring pesticides. Science. 1984;226:184\u2013187.", "ArticleIdList": ["6207592"]}, {"Citation": "Sledz W., Los E., Paczek A., Rischka J., Motyka A., Zoledowska S. Antibacterial activity of caffeine against plant pathogenic bacteria. Acta Biochim. Pol. 2015;62:605\u2013612.", "ArticleIdList": ["26307771"]}, {"Citation": "Cappelletti S., Piacentino D., Daria P., Sani G., Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Curr. Neuropharmacol. 2015;13:71\u201388.", "ArticleIdList": ["PMC4462044", "26074744"]}, {"Citation": "Coelho A., Fraichard S., Le Goff G., Faure P., Artur Y., Ferveur J.-F. Cytochrome P450-dependent metabolism of caffeine in Drosophila melanogaster. PLoS One. 2015;10", "ArticleIdList": ["PMC4324904", "25671424"]}, {"Citation": "Lisko J.G., Lee G.E., Kimbrell J.B., Rybak M.E., Valentin-Blasini L., Watson C.H. Caffeine concentrations in coffee, tea, chocolate, and energy drink flavored E-liquids. Nicotine Tob. Res. 2016;31:ntw192.", "ArticleIdList": ["PMC5568045", "27613945"]}, {"Citation": "Fisone G., Borgkvist A., Usiello A. Caffeine as a psychomotor stimulant: mechanism of action. Cell. Mol. Life Sci. 2004;61:857\u2013872.", "ArticleIdList": ["15095008"]}, {"Citation": "Pennella S., Vittoria Mattioli A. Caffeine, energy drinks and atrial fibrillation: a Mini-Review. BAOJ Nutr. 2015;1:1\u20134."}, {"Citation": "Graham T.E., Rush J.W.E., van Soeren M.H. Caffeine and exercise: metabolism and performance. Can. J. Appl. Physiol. 1994;19:111\u2013138.", "ArticleIdList": ["8081318"]}, {"Citation": "Chen M.D., Lin W.H., Song Y.M., Lin P.Y., Ho L.T. Effect of caffeine on the levels of brain serotonin and catecholamine in the genetically obese mice. Zhonghua Yixue Zazhi. 1994;53:257\u2013261.", "ArticleIdList": ["8039038"]}, {"Citation": "Szopa A., Poleszak E., Wyska E., Serefko A., Wo\u015bko S., Wla\u017a A. Caffeine enhances the antidepressant-like activity of common antidepressant drugs in the forced swim test in mice. Naunyn-Schmiedeberg\u2019s Arch. Pharmacol. 2016;389:211\u2013221.", "ArticleIdList": ["PMC4715838", "26614569"]}, {"Citation": "Chapman R.F., Mickleborough T.D. The effects of caffeine on ventilation and pulmonary function during exercise: an often-overlooked response. Phys. Sportsmed. 2009;37:97\u2013103.", "ArticleIdList": ["20048546"]}, {"Citation": "Benfey B.G. Theophylline and phenylephrine effects on cardiac relaxation. Br. J. Pharmacol. 1977;59:75\u201381.", "ArticleIdList": ["PMC1667699", "837009"]}, {"Citation": "Yu G., Maskray V., Jackson S., Swift C., Tiplady B. A comparison of the central nervous system effects of caffeine and theophylline in elderly subjects. Br. J. Clin. Pharmacol. 1991;32:341\u2013345.", "ArticleIdList": ["PMC1368528", "1777371"]}, {"Citation": "Rabe K.F., Magnussen H., Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur. Respir. J. 1995;8:637\u2013642.", "ArticleIdList": ["7664866"]}, {"Citation": "Bell M., Jackson E., Mi Z., McCombs J., Carcillo J. Low-dose theophylline increases urine output in diuretic-dependent critically ill children. Intensive Care Med. 1998;24:1099\u20131105.", "ArticleIdList": ["9840247"]}, {"Citation": "Boison D. Methylxanthines, seizures, and excitotoxicity. Handb. Exp. Pharmacol. 2011;200:251\u2013266.", "ArticleIdList": ["PMC2945384", "20859799"]}, {"Citation": "Spatafora M., Chiappara G., Merendino A.M., D\u2019Amico D., Bellia V., Bonsignore G. Theophylline suppresses the release of tumour necrosis factor-alpha by blood monocytes and alveolar macrophages. Eur. Respir. J. 1994;7:223\u2013228.", "ArticleIdList": ["8162974"]}, {"Citation": "Foukas L.C., Daniele N., Ktori C., Anderson K.E., Jensen J., Shepherd P.R. Direct effects of caffeine and theophylline on p110\u03b4 and other phosphoinositide 3-kinases: differential effects on lipid kinase and protein kinase activities. J. Biol. Chem. 2002;277:37124\u201337130.", "ArticleIdList": ["12145276"]}, {"Citation": "Sugimura K., Mizutani A. The inhibitory effect of xanthine derivatives on alkaline phosphatase in the rat brain. Histochemistry. 1979;61:131\u2013137.", "ArticleIdList": ["88432"]}, {"Citation": "Glogowski J., Danforth D.R., Ciereszko A. Inhibition of alkaline phosphatase activity of boar semen by pentoxifylline, caffeine, and theophylline. J. Androl. 2002;23:783\u2013792.", "ArticleIdList": ["12399523"]}, {"Citation": "Ashihara H., Crozier A. Biosynthesis and metabolism of caffeine and related purine alkaloids in plants. Adv. Bot. Res. 1999;30:117\u2013205."}, {"Citation": "Naotoshi Katakura M., Matsuzaki K., Ohno-Shosaku T., Yachie A., Shido O. Vol. 30. Federation of American Societies for Experimental Biology; 2016. (Federation Proceedings)."}, {"Citation": "Slattery M.L., West D.W. Smoking, alcohol, coffee, tea, caffeine, and theobromine: risk of prostate cancer in Utah (United States) Cancer Causes Control. 1993;4:559\u2013563.", "ArticleIdList": ["8280834"]}, {"Citation": "Barcz E., Sommer E., Janik P., Marianowski L., Skopinska-R\u00f3zewska E. Adenosine receptor antagonism causes inhibition of angiogenic activity of human ovarian cancer cells. Oncol. Rep. 2000;7:1285\u20131291.", "ArticleIdList": ["11032931"]}, {"Citation": "Kakuyama (nee Iwazaki) A., Sadzuka Y. Effect of methylxanthine derivatives on doxorubicin transport and antitumor activity. Curr. Drug Metabol. 2001;2:379\u2013395.", "ArticleIdList": ["11766989"]}, {"Citation": "Usmani O.S., Belvisi M.G., Patel H.J., Crispino N., Birrell M.A., Korbonits M. Theobromine inhibits sensory nerve activation and cough. Faseb. J. 2005;19:231\u2013233.", "ArticleIdList": ["15548587"]}, {"Citation": "Orr\u00fa M., Guitart X., Karcz-Kubicha M., Solinas M., Justinova Z., Barodia S.K. Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans. Neuropharmacology. 2013;67:476\u2013484.", "ArticleIdList": ["PMC3562388", "23261866"]}, {"Citation": "Hawke T.J., Allen D.G., Lindinger M.I. Paraxanthine, a caffeine metabolite, dose dependently increases [Ca2+]i in skeletal muscle. J. Appl. Physiol. 2000;89:2312\u20132317.", "ArticleIdList": ["11090584"]}, {"Citation": "Toxicol J.D.M., Kebamo S., Tesema S., Geleta B. The role of biotransformation in drug discovery and development. Drug Metab. Toxicol. 2015;6:1\u201313."}, {"Citation": "Warren R.N. Metabolism of xanthine alkaloids in man. J. Chromatogr. 1969;40:468\u2013469.", "ArticleIdList": ["5780522"]}, {"Citation": "Chung W.-G., Cha Y.-N. Oxidation of caffeine to theobromine and theophylline is catalyzed primarily by flavin-containing monooxygenase in liver microsomes. Biochem. Biophys. Res. Commun. 1997;235:685\u2013688.", "ArticleIdList": ["9207220"]}, {"Citation": "Kalberer P. Breakdown of caffeine in the leaves of coffea arabica L. Nature. 1965;205:597\u2013598."}, {"Citation": "Suzuki T., Waller G.R. Biodegradation of caffeine: formation of theophylline and theobromine from caffeine in matureCoffea arabica fruits. J. Sci. Food Agric. 1984;35:66\u201370."}, {"Citation": "Suzuki T., Waller G.R. Biosynthesis and biodegradation of caffeine, theobromine, and theophylline in Coffea arabica L. fruits. J. Agric. Food Chem. 1984;32:845\u2013848."}, {"Citation": "Asano Y., Komeda T., Yamada H. Microbial production of theobromine from caffeine. Biosci. Biotechnol. Biochem. 1993;57:1286\u20131289."}, {"Citation": "Babu V.R.S., Patra S., Thakur M.S., Karanth N.G., Varadaraj M.C. Degradation of caffeine by Pseudomonas alcaligenes CFR 1708. Enzym. Microb. Technol. 2005;37:617\u2013624."}, {"Citation": "Schwimmer S., Kurtzman R.H., Heftmann E. Caffeine metabolism by Penicillium roqueforti. Arch. Biochem. Biophys. 1971;147:109\u2013113.", "ArticleIdList": ["5114925"]}, {"Citation": "Retnadhas S., Gummadi S.N. Bioprocessing & biotechniques optimization of process conditions for biotransformation of caffeine to theobromine using induced whole cells of Pseudomonas sp. J. Bioprocess. Biotech. 2014;4"}, {"Citation": "Ashihara H., Sano H., Crozier A. Caffeine and related purine alkaloids: biosynthesis, catabolism, function and genetic engineering. Phytochemistry. 2008;69:841\u2013856.", "ArticleIdList": ["18068204"]}, {"Citation": "BK Campbell, KN Campbell. Method of preparing xanthine and methylated xanthines. US Pat 1948; US2523496A."}, {"Citation": "Salda\u00f1a M.D.A., Mohamed R.S., Baer M.G., Mazzafera P., Han J., Deng W. Direct conversion of theophylline to 3-methylxanthine by metabolically engineered E. coli. J. Agric. Food Chem. 1999;47:3804\u20133808.", "ArticleIdList": ["0"]}, {"Citation": "Aleksandrova E.V., Levich S.V., Romanenko N.I., Shkoda A.S., Mikhal\u2032chenko E.K. Synthesis, transformations, and physicochemical properties of 3-(4\u2032-Methylphenyl)-8-methylxanthine derivatives. Chem. Nat. Compd. 2014;49:1105\u20131109."}, {"Citation": "Algharrawi K.H.R., Summers R.M., Gopishetty S., Subramanian M. Direct conversion of theophylline to 3-methylxanthine by metabolically engineered E. coli. Microb. Cell Factories. 2015;14:203.", "ArticleIdList": ["PMC4687300", "26691652"]}, {"Citation": "Rutherford J.D., Vatner S.F., Braunwald E. Effects and mechanism of action of aminophylline on cardiac function and regional blood flow distribution in conscious dogs. Circulation. 1981;63:378\u2013387.", "ArticleIdList": ["6108802"]}, {"Citation": "Skinh\u00f8j E., Paulson O.B. The mechanism of action of aminophylline upon cerebral vascular disorders. Acta Neurol. Scand. 1970;46:129\u2013140.", "ArticleIdList": ["5431453"]}, {"Citation": "Roy U., Pal M., Datta S., Harlalka S. Has oxidative stress any role on mechanisms of aminophylline \u2013 induced seizures? An animal study. Kathmandu Univ. Med. J. 2015;12:269.", "ArticleIdList": ["26333582"]}, {"Citation": "Geisbuhler T.P., Schwager T.L., Ervin H.D. 3-Isobutyl-1-methylxanthine (IBMX) sensitizes cardiac myocytes to anoxia. Biochem. Pharmacol. 2002;63:2055\u20132062.", "ArticleIdList": ["12093483"]}, {"Citation": "Huai Q., Wang H., Zhang W., Colman R.W., Robinson H., Ke H. Crystal structure of phosphodiesterase 9 shows orientation variation of inhibitor 3-isobutyl-1-methylxanthine binding. Proc. Natl. Acad. Sci. U. S. A. 2004;101:9624\u20139629.", "ArticleIdList": ["PMC470725", "15210993"]}, {"Citation": "Zhang X., Feng Q., Cote R.H. Efficacy and selectivity of phosphodiesterase-targeted drugs in inhibiting photoreceptor phosphodiesterase (PDE6) in retinal photoreceptors. Invest. Ophthalmol. Vis. Sci. 2005;46:3060\u20133066.", "ArticleIdList": ["PMC1343468", "16123402"]}, {"Citation": "Usachev Y., Verkhratsky A. IBMX induces calcium release from intracellular stores in rat sensory neurones. Cell Calcium. 1995;17:197\u2013206.", "ArticleIdList": ["7542569"]}, {"Citation": "Hoshino T., Matsuda M., Yamashita Y., Takehara M., Fukuya M., Mineda K. Suppression of melanin production by expression of HSP70. J. Biol. Chem. 2010;285:13254\u201313263.", "ArticleIdList": ["PMC2857129", "20177067"]}, {"Citation": "Wells J.N., Miller J.R. Methylxanthine inhibitors of phosphodiesterases. Methods Enzymol. 1988;159:489\u2013496.", "ArticleIdList": ["2457788"]}, {"Citation": "Ho Sam Ahn, Crim W., Romano M., Sybertz E., Pitts B. Effects of selective inhibitors on cyclic nucleotide phosphodiesterases of rabbit aorta. Biochem. Pharmacol. 1989;38:3331\u20133339.", "ArticleIdList": ["2554921"]}, {"Citation": "Samlaska C.P., Winfield E.A. Pentoxifylline. J. Am. Acad. Dermatol. 1994;30:603\u2013621.", "ArticleIdList": ["8157787"]}, {"Citation": "Beebe H.G., Dawson D.L., Cutler B.S., Herd J.A., Strandness D.E., Bortey E.B. A new pharmacological treatment for intermittent claudication. Arch. Intern. Med. 1999;159:2041.", "ArticleIdList": ["10510990"]}, {"Citation": "Ward A., Clissold S.P. Pentoxifylline.Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs. 1987;34:50\u201397.", "ArticleIdList": ["3308412"]}, {"Citation": "Tarhan O.R., Barut I., Sutcu R., Akdeniz Y., Akturk O. Pentoxifylline, a Methyl xanthine derivative, reduces peritoneal adhesions and increases peritoneal fibrinolysis in rats. Tohoku J. Exp. Med. 2006;209:249\u2013255.", "ArticleIdList": ["16778372"]}, {"Citation": "Steinleitner A., Lambert H., Kazensky C., Danks P., Roy S. Pentoxifylline, a methylxanthine derivative, prevents postsurgical adhesion reformation in rabbits. Obstet. Gynecol. 1990;75:926\u2013928.", "ArticleIdList": ["2342738"]}, {"Citation": "Hassan I., Dorjay K., Anwar P. Pentoxifylline and its applications in dermatology. Indian Dermatol. Online J. 2014;5:510\u2013516.", "ArticleIdList": ["PMC4228656", "25396144"]}, {"Citation": "Bondan E.F., De F\u00e1tima M., Martins M., Bernardi M.M. Propentofylline reverses delayed remyelination in streptozotocin- induced diabetic rats. Arch. Endocrinol. Metab. 2015;59:47\u201353.", "ArticleIdList": ["25926114"]}, {"Citation": "Vukadinovi\u0107a V., Stefanovich V., Raki\u0107a L. Effect of propentofylline on the GABA system of a rat brain. Drug Dev. Res. 1986;7:87\u201394."}, {"Citation": "Gwak Y.S., Crown E.D., Unabia G.C., Hulsebosch C.E. Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat. Pain. 2008;138:410\u2013422.", "ArticleIdList": ["PMC2676790", "18353556"]}, {"Citation": "Rudolphi K., Park C.K., Rother M. Propentofylline (HWA 285), a neuroprotective glial cell modulator: pharmacologic profile. CNS Drug Rev. 1997;3:260\u2013277."}, {"Citation": "Jacobs V.L., Landry R.P., Liu Y., Romero-Sandoval E.A., De Leo J.A. Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia. Neuro Oncol. 2012;14:119\u2013131.", "ArticleIdList": ["PMC3266380", "22086978"]}, {"Citation": "Stefanovich V. Effect of propentofylline on cerebral metabolism of rats. Drug Dev. Res. 1985;6:327\u2013338."}, {"Citation": "Deleo J., Schubert P., Kreutzberg G.W. Protection against ischemic brain damage using propentofylline in gerbils. Stock. 1987;19:1535\u20131539.", "ArticleIdList": ["3201513"]}, {"Citation": "Dini F.L., Doxofylline Cogo R. A new generation xanthine bronchodilator devoid of major cardiovascular adverse effects. Curr. Med. Res. Opin. 2000;16:258\u2013268.", "ArticleIdList": ["11268710"]}, {"Citation": "Gupta A., Yadav V., Yadav J.S., Rawat S. An analytical approach of doxofylline: a review. Asian J. Pharm. Anal. 2011;1:67\u201370."}, {"Citation": "van Mastbergen J., Jolas T., Allegra L., Page C.P. The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism. Pulm. Pharmacol. Ther. 2012;25:55\u201361.", "ArticleIdList": ["22138191"]}, {"Citation": "Wu B.-N., Lin R.-J., Lin C.-Y., Shen K.-P., Chiang L.-C., Chen I.-J. A xanthine-based KMUP-1 with cyclic GMP enhancing and K + channels opening activities in rat aortic smooth muscle. Br. J. Pharmacol. 2001;134:265\u2013274.", "ArticleIdList": ["PMC1572942", "11564644"]}, {"Citation": "Lin R.-J., Wu B.-N., Shen K.-P., Huang C.-H., Liu Z.-I., Lin C.-Y. Xanthine-analog, KMUP-2, enhances cyclic GMP and K+ channel activities in rabbit aorta and corpus cavernosum with associated penile erection. Drug Dev. Res. 2002;55:162\u2013172."}, {"Citation": "Liu C.-P., Yeh J.-L., Wu B.-N., Chai C.-Y., Chen I.-J., Lai W.-T. KMUP-3 attenuates ventricular remodelling after myocardial infarction through eNOS enhancement and restoration of MMP-9/TIMP-1 balance. Br. J. Pharmacol. 2011;162:126\u2013135.", "ArticleIdList": ["PMC3012411", "20840538"]}, {"Citation": "I-J Chen. Processes for preparing piperazinium salts of KMUP and use thereof. United States Pat US 8,470 2010;805."}, {"Citation": "Liu C.-P., Yeh J.-L., Liou S.-F., Wu B.-N., Chen I.-J. Phosphodiesterase inhibitor KMUP-3 displays cardioprotection via protein kinase G and increases cardiac output via G-protein-coupled receptor agonist activity and Ca2+ sensitization. Kaohsiung J. Med. Sci. 2016;32:55\u201367.", "ArticleIdList": ["26944323"]}, {"Citation": "Wu B.-N., Chen I.-C., Lin R.-J., Chiu C.-C., An L.-M., Chen I.-J. Aortic smooth muscle relaxants KMUP-3 and KMUP-4, two nitrophenylpiperazine derivatives of xanthine, display cGMP-enhancing activity. J. Cardiovasc. Pharmacol. 2005;46:600\u2013608.", "ArticleIdList": ["16220066"]}, {"Citation": "Liou S.-F., Hsu J.-H., Lin I.-L., Ho M.-L., Hsu P.-C., Chen L.-W. KMUP-1 suppresses RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss: roles of MAPKs, Akt, NF-\u03baB and Calcium/Calcineurin/NFATc1 Pathways. PLoS One. 2013;8", "ArticleIdList": ["PMC3723916", "23936022"]}, {"Citation": "Chung H.-H., Dai Z.-K., Wu B.-N., Yeh J.-L., Chai C.-Y., Chu K.-S. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase. Br. J. Pharmacol. 2010;160:971\u2013986.", "ArticleIdList": ["PMC2936002", "20590592"]}, {"Citation": "Hong T.Y., Guh J.Y., Wu B.N., Chai C.Y., Huang H.T., Chen I.J. KMUP-1 protects kidney from streptozotocin-induced pro-inflammation in early diabetic nephropathy by restoring enos/ppar\u03b3 and inhibiting MMP-9. Eur. J. Inflamm. 2014;12:89\u2013100."}, {"Citation": "Yeh J.-L., Liu C.-P., Hsu J.-H., Tseng C.-J., Wu P.-J., Wang Y.-Y. KMUP-1 inhibits hypertension-induced left ventricular hypertrophy through regulation of nitric oxide synthases, ERK1/2, and calcineurin. Kaohsiung J. Med. Sci. 2012;28:567\u2013576.", "ArticleIdList": ["23140764"]}, {"Citation": "Cushley M.J., Holgate S.T. Bronchodilator actions of xanthine derivatives administered by inhalation in asthma. Thorax. 1985;40:176\u2013179.", "ArticleIdList": ["PMC460019", "3983884"]}, {"Citation": "Zuidema J., Merkus F.W.H.M. Pharmacokinetics and pharmacodynamics of diprophylline. Pharm. Weekbl. - Sci. Ed. 1981;3:1320\u20131325."}, {"Citation": "Hasegawa T., Nadai M., Apichartpichean R., Muraoka I., Nabeshima T., Takagi K. Pharmacokinetic characteristics of N7-substituted theophylline derivatives and their interaction with quinolone in rats. J. Pharm. Sci. 1991;80:962\u2013965.", "ArticleIdList": ["1664467"]}, {"Citation": "Cosio B.G., Tsaprouni L., Ito K., Jazrawi E., Adcock I.M., Barnes P.J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J. Exp. Med. 2004;200:689\u2013695.", "ArticleIdList": ["PMC2212744", "15337792"]}, {"Citation": "Ito K., Caramori G., Lim S., Oates T., Chung K.F., Barnes P.J. Expression and activity of histone deacetylases in human asthmatic airways. Am. J. Respir. Crit. Care Med. 2002;166:392\u2013396.", "ArticleIdList": ["12153977"]}, {"Citation": "Grome J.J., Hofmann W., Gojowczyk G., Stefanovich V. Effects of a xanthine derivative, propentofylline, on local cerebral blood flow and glucose utilization in the rat. Brain Res. 1996;740:41\u201346.", "ArticleIdList": ["8973796"]}, {"Citation": "Mielke R., Kittner B., Ghaemi M., Kessler J., Szelies B., Herholz K. Propentofylline improves regional cerebral glucose metabolism and neuropsychologic performance in vascular dementia. J. Neurol. Sci. 1996;141:59\u201364.", "ArticleIdList": ["8880694"]}, {"Citation": "M\u00fcller C.E., Jacobson K.A. Xanthines as adenosine receptor antagonists. NIH Publ. Access. 2011", "ArticleIdList": ["PMC3882893", "20859796"]}, {"Citation": "Haghgoo S., Hasegawa T., Nadai M., Wang L., Ishigaki T., Miyamoto K.-I. Brain distribution characteristics of xanthine derivatives and relation to their locomotor activity in mice. J. Pharm. Pharmacol. 1995;47:412\u2013419.", "ArticleIdList": ["7494193"]}, {"Citation": "Spina D., Page C.P. Handb. Exp. Pharmacol. Springer; Cham: 2016. Xanthines and Phosphodiesterase Inhibitors; pp. 63\u201391.", "ArticleIdList": ["27844172"]}, {"Citation": "Zainab S., Djafarian K. Coffee consumption and coronary heart diseases: a mini-review. J. Clin. Nutr. Diet. 2016;2:1\u20137."}, {"Citation": "Osswald H., Schnermann J. Springer Berlin Heidelberg; 2011. Methylxanthines and the Kidney; pp. 391\u2013412.", "ArticleIdList": ["PMC3275788", "20859805"]}, {"Citation": "Rieg T., Steigele H., Schnermann J., Richter K., Osswald H., Vallon V. Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J. Pharmacol. Exp. Ther. 2005;313:403\u2013409.", "ArticleIdList": ["15590766"]}, {"Citation": "Bhatia M.S., Waghmare V.S., Choudhari P.B., Kumbhar S.S. Synthesis and biological activity of xanthene derivatives as antiasthamatic agents. RGUHS J. Pharm. Sci. 2016;6:26\u201331."}, {"Citation": "Lin R.J., Wu B.N., Lo Y.C., An L.M., Dai Z.K., Lin Y.T. A xanthine-based epithelium-dependent airway relaxant KMUP-3 (7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine) increases respiratory performance and protects against tumor necrosis factor-alpha-induced tracheal contraction, involving nitri. J. Pharmacol. Exp. Ther. 2006;316:709\u2013717.", "ArticleIdList": ["16234412"]}, {"Citation": "Lazzaroni M., Grossi E., Porro G.B. The effect of intravenous doxofylline or aminophylline on gastric secretion in duodenal ulcer patients. Aliment Pharmacol. Ther. 2007;4:643\u2013649.", "ArticleIdList": ["2129651"]}, {"Citation": "Sachdeva S., Gupta M. Adenosine and its receptors as therapeutic targets: an overview. Saudi Pharm. J. 2013;21:245\u2013253.", "ArticleIdList": ["PMC3744929", "23960840"]}, {"Citation": "St. Hilaire C., Carroll S.H., Chen H., Ravid K. Mechanisms of induction of adenosine receptor genes and its functional significance. J. Cell. Physiol. 2009;218:35\u201344.", "ArticleIdList": ["PMC3265330", "18767039"]}, {"Citation": "Franchetti P., Messini L., Cappellacci L., Grifantini M., Lucacchini A., Martini C. 8-Azaxanthine derivatives as antagonists of adenosine receptors. J. Med. Chem. 1994;37:2970\u20132975.", "ArticleIdList": ["8071944"]}, {"Citation": "Jacobson K.A., Gao Z.-G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 2006;5:247\u2013264.", "ArticleIdList": ["PMC3463109", "16518376"]}, {"Citation": "van Galen P.J.M., Stiles G.L., Michaels G., Jacobson K.A. Adenosine A1 and A2 receptors: structure\u2013function relationships. Med. Res. Rev. 1992;12:423\u2013471.", "ArticleIdList": ["PMC3448285", "1513184"]}, {"Citation": "Francis S.H., Blount M.A., Corbin J.D. Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions. Physiol. Rev. 2011;91:651\u2013690.", "ArticleIdList": ["21527734"]}, {"Citation": "Mehats C., Andersen C.B., Filopanti M., Jin S.-L.C., Conti M. Cyclic nucleotide phosphodiesterases and their role in endocrine cell signaling. Trends Endocrinol. Metab. 2002;13:29\u201335.", "ArticleIdList": ["0"]}, {"Citation": "Omori K., Kotera J. Overview of PDEs and their regulation. Circ. Res. 2007;100:309\u2013327.", "ArticleIdList": ["17307970"]}, {"Citation": "Ke H., Wang H., Ye M. Structural insight into the substrate specificity of phosphodiesterases. Handb. Exp. Pharmacol. 2011:121\u2013134.", "ArticleIdList": ["21695637"]}, {"Citation": "Maurice D.H., Ke H., Ahmad F., Wang Y., Chung J., Manganiello V.C. Advances in targeting cyclic nucleotide phosphodiesterases. Nat. Rev. Drug Discov. 2014;13:290\u2013314.", "ArticleIdList": ["PMC4155750", "24687066"]}, {"Citation": "Shao Y., Huang M., Cui W., Feng L., Wu Y., Cai Y. 2014. Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent.", "ArticleIdList": ["PMC4281101", "25432025"]}, {"Citation": "Andreeva S.G., Dikkes P., Epstein P.M., Rosenberg P.A. Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain. J. Neurosci. 2001;21:9068\u20139076.", "ArticleIdList": ["PMC6762294", "11698617"]}, {"Citation": "Singh N., Patra S. Phosphodiesterase 9: insights from protein structure and role in therapeutics. Life Sci. 2014;106:1\u201311.", "ArticleIdList": ["24746902"]}, {"Citation": "Boswell-Smith V., Cazzola M., Page C.P. Are phosphodiesterase 4 inhibitors just more theophylline? J. Allergy Clin. Immunol. 2006;117:1237\u20131243.", "ArticleIdList": ["16750981"]}, {"Citation": "Yano Y., Yoshida M., Hoshino S., Inoue K., Kida H., Yanagita M. Anti-fibrotic effects of theophylline on lung fibroblasts. Biochem. Biophys. Res. Commun. 2006;341:684\u2013690.", "ArticleIdList": ["16430859"]}, {"Citation": "Hosseinzadeh H., Fazly Bazzaz B.S., Moaddab Sadati M. In\u00a0vitro evaluation of methylxanthines and some antibiotics: interaction against Staphylococcus aureus and Pseudomonas aeruginosa. Iran. Biomed. J. 2006;10:163\u2013167."}, {"Citation": "Peter T., Barnes J. Theophylline. Pharmaceuticals. 2010;3:725\u2013747.", "ArticleIdList": ["PMC4033977", "27713276"]}, {"Citation": "Katherine Aleksandrova, Belenichev Igor, Alexander Shkoda, Levich Sergey, Yurchenko Darja, Buchtiyarova Nina. Research of antioxidant properties of theophyllinyl-7-acetic acid derivatives. Med. Sci. 2014;3:187\u2013194."}, {"Citation": "Vignoli J.A., Bassoli D.G., Benassi M.T. Antioxidant activity, polyphenols, caffeine and melanoidins in soluble coffee: the influence of processing conditions and raw material. Food Chem. 2011;124:863\u2013868."}, {"Citation": "Yashin A., Yashin Y., Wang J.Y., Nemzer B. Antioxidant and antiradical activity of coffee. Antioxidants. 2013;2:230\u2013245.", "ArticleIdList": ["PMC4665516", "26784461"]}, {"Citation": "Sadzuka Y., Iwazaki A., Miyagishima A., Nozawa Y., Hirota S. Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity. Jpn. J. Cancer Res. 1995;86:594\u2013599.", "ArticleIdList": ["PMC5920866", "7622424"]}, {"Citation": "Li F., Zheng C., Xin J., Chen F., Ling H., Sun L. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base. Int. J. Nanomed. 2016;11:3875\u20133890.", "ArticleIdList": ["PMC4990380", "27574421"]}, {"Citation": "Zhang Y., Yu J., Zhang L., Cai J., Cai D., Lv C. Enhanced anti-tumor effects of doxorubicin on glioma by entrapping in polybutylcyanoacrylate nanoparticles. Tumor Biol. 2016;37:2703\u20132708.", "ArticleIdList": ["26404136"]}, {"Citation": "Hinze H.-J. Vieweg+Teubner Verlag; Methylxanthine, Wiesbaden: 1982. Analytic and pharmacokinetic data of natural methylxanthines and of the xanthine derivative pentoxifylline. Theophylline other Methylxanthines/Theophyllin und And; pp. 55\u201361."}, {"Citation": "Bruns R.F., Fergus J.H. Solubilities of adenosine antagonists determined by radioreceptor assay. J. Pharm. Pharmacol. 1989;41:590\u2013594.", "ArticleIdList": ["2573701"]}, {"Citation": "Andrei K. 2011. Solubility and Physical Stability Improvement of Natural Xanthine Derivates."}, {"Citation": "Aslaksen A., Bakke O., Vigander T. Comparative pharmacokinetics of theophylline and aminophylline in man. Br. J. Clin. Pharmacol. 1981;11:269\u2013273.", "ArticleIdList": ["PMC1401615", "7213528"]}, {"Citation": "Fredholm B.B., Jacobson K.A., Jonzon B., Kirk K.L., Li Y.O., Daly J.W. Evidence that a Novel 8-phenyl\u2013substituted xanthine derivative is a cardioselective adenosine receptor antagonist in\u00a0Vivo. J. Cardiovasc. Pharmacol. 1987;9:396\u2013400.", "ArticleIdList": ["PMC4351551", "2438501"]}, {"Citation": "Chappe V., Mettey Y., Vierfond J.M., Hanrahan J.W., Gola M., Verrier B. Structural basis for specificity and potency of xanthine derivatives as activators of the CFTR chloride channel. Br. J. Pharmacol. 1998;123:683\u2013693.", "ArticleIdList": ["PMC1565206", "9517388"]}, {"Citation": "Takagi K., Hasegawa T., Kuzuya T., Ogawa K., Watanabe T., Satake T. Structure-activity relationship in N3-alkyl-xanthine derivatives. Jpn. J. Pharmacol. 1988;46:373\u2013378.", "ArticleIdList": ["3404767"]}, {"Citation": "Miyamoto K., Kurita M., Ohmae S., Sakai R., Sanae F., Takagi K. Selective tracheal relaxation and phosphodiesterase-IV inhibition by xanthine derivatives. Eur. J. Pharmacol. 1994;267:317\u2013322.", "ArticleIdList": ["8088370"]}, {"Citation": "Schwabe U., Ukena D., Lohse M.J. Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1985;330:212\u2013221.", "ArticleIdList": ["2997628"]}, {"Citation": "Abdulrahman L.K., Al-Mousilly M.M., Al-Halaibeh T.S., Al-Azzawii K.M. International research journal of pharmacy synthesis of new 1, 3, 7, 8-tetrasubstituted xanthenes analogue. Int. Res. J. Pharm. 2012;3:83\u201385."}, {"Citation": "Laddha S.S., Wadodkar S.G., Meghal S.K. CAMP-dependent phosphodiesterase inhibition and SAR studies on novel 6,8-disubstituted 2-phenyl-3-(substituted benzothiazole-2-yl)-4[3H]- quinazolinone. Med. Chem. Res. 2009;18:268\u2013276."}, {"Citation": "Kadi A.A., El-Tahir K.E.H., Jahng Y., Rahman A.F.M.M. Synthesis, biological evaluation and Structure Activity Relationships (SARs) study of 8-(substituted)aryloxycaffeine. Arab J. Chem. 2015"}, {"Citation": "Jacobson K.A., de la Cruz R., Schulick R., Kiriasis L., Padgett W., Pfleiderer W. 8-Substituted xanthines as antagonists at A1- and A2-adenosine receptors. Biochem. Pharmacol. 1988;37:3653\u20133661.", "ArticleIdList": ["PMC3469272", "3178879"]}, {"Citation": "Rogozin E.A., Lee K.W., Kang N.J., Yu H., Nomura M., Miyamoto K. Inhibitory effects of caffeine analogues on neoplastic transformation structure\u2013activity relationship.pdf. Carcinogenesis. 2008;29:1228\u20131234.", "ArticleIdList": ["PMC2830620", "18195054"]}, {"Citation": "Daly J.W., Hong O., Padgett W.L., Shamim M.T., Jacobson K.A., Ukena D. Non-xanthine heterocycles: activity as antagonists of A1 and A2-adenosine receptors. Biochem. Pharmacol. 1988;37:655\u2013664.", "ArticleIdList": ["PMC3445624", "2829919"]}, {"Citation": "Schneller S.W., Ibay A.C., Christ W.J., Bruns R.F. Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists. J. Med. Chem. 1989;32:2247\u20132254.", "ArticleIdList": ["2795597"]}, {"Citation": "Daly J.W., Hide I., Bridson P.K. Imidazodiazepinediones: a new class of adenosine receptor antagonists. J. Med. Chem. 1990;33:2818\u20132821.", "ArticleIdList": ["2213834"]}, {"Citation": "Ivanov E.I., Polishchuk A.A., Kalayanov G.D. Synthesis of crown-containing xanthine derivatives. Chem. Heterocycl. Comp. 1992;28:1266\u20131269."}, {"Citation": "Elzein E., Kalla R.V., Li X., Perry T., Gimbel A., Zeng D. Discovery of a novel A2B adenosine receptor antagonist as a clinical candidate for chronic inflammatory airway diseases. J. Med. Chem. 2008;51:2267\u20132278.", "ArticleIdList": ["18321039"]}, {"Citation": "Soriano A., Ventura R., Molero A., Hoen R., Casado V., Corte A. Adenosine A2A receptor-antagonist/dopamine D2 receptor-agonist bivalent ligands as pharmacological tools to detect A 2A-D2 receptor heteromers. J. Med. Chem. 2009;52:5590\u20135602.", "ArticleIdList": ["19711895"]}]}], "History": [{"Year": "2018", "Month": "6", "Day": "21"}, {"Year": "2018", "Month": "9", "Day": "25"}, {"Year": "2018", "Month": "9", "Day": "25"}, {"Year": "2018", "Month": "10", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "10", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2018", "Month": "10", "Day": "3"}], "PublicationStatus": "epublish", "ArticleIdList": ["30302410", "PMC6174542", "10.1016/j.heliyon.2018.e00829", "S2405-8440(18)33100-1"]}}]}